Total Payments
$65,736
2024 Payments
$7,147
Companies
91
Transactions
1,445
Medicare Patients
10,885
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$29,587 (45.0%)
Other$28,513 (43.4%)
Consulting$5,675 (8.6%)
Education$1,024 (1.6%)
Travel$937.34 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $29,587 | 1,388 | 45.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $28,513 | 19 | 43.4% |
| Consulting Fee | $5,675 | 3 | 8.6% |
| Education | $1,024 | 32 | 1.6% |
| Travel and Lodging | $937.34 | 3 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $32,158 | 96 | $0 (2024) |
| Celgene Corporation | $4,147 | 60 | $0 (2024) |
| ADC Therapeutics America, Inc. | $2,096 | 5 | $0 (2024) |
| PFIZER INC. | $1,652 | 102 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,552 | 63 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,531 | 80 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,460 | 72 | $0 (2024) |
| Amgen Inc. | $1,361 | 56 | $0 (2023) |
| Janssen Biotech, Inc. | $1,244 | 59 | $0 (2024) |
| Genentech USA, Inc. | $1,184 | 65 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,147 | 223 | ADC Therapeutics America, Inc. ($2,072) |
| 2023 | $5,766 | 244 | PFIZER INC. ($403.38) |
| 2022 | $10,201 | 254 | Lilly USA, LLC ($5,219) |
| 2021 | $18,910 | 179 | Lilly USA, LLC ($15,429) |
| 2020 | $13,723 | 79 | Lilly USA, LLC ($9,930) |
| 2019 | $3,070 | 114 | Lilly USA, LLC ($940.02) |
| 2018 | $3,235 | 165 | Novartis Pharmaceuticals Corporation ($336.50) |
| 2017 | $3,684 | 187 | Amgen Inc. ($438.45) |
All Payment Transactions
1,445 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $35.37 | General |
| Category: Oncology | ||||||
| 12/24/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Oncology | ||||||
| 12/23/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $33.75 | General |
| Category: Oncology | ||||||
| 12/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: ONCOLOGY | ||||||
| 12/19/2024 | SERVIER PHARMACEUTICALS LLC | — | Food and Beverage | In-kind items and services | $24.97 | General |
| 12/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Oncology | ||||||
| 12/18/2024 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $33.84 | General |
| Category: Oncology | ||||||
| 12/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $33.82 | General |
| Category: Oncology | ||||||
| 12/13/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $27.49 | General |
| 12/12/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Oncology | ||||||
| 12/10/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $33.84 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $19.45 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $6.49 | General |
| Category: Hematology | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $1.94 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $25.10 | General |
| Category: Hematology | ||||||
| 11/27/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: Oncology | ||||||
| 11/25/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $32.43 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | Genentech USA, Inc. | Itovebi (Biological), Tecentriq Hybreza | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 47 | 2,972 | 118,678 | $2.1M | $702,320 |
| 2022 | 40 | 2,842 | 61,713 | $1.5M | $509,217 |
| 2021 | 35 | 2,528 | 44,630 | $1.3M | $495,237 |
| 2020 | 34 | 2,543 | 47,351 | $1.2M | $440,080 |
Total Patients
10,885
Total Services
272,372
Medicare Billing
$2.1M
Procedure Codes
156
All Medicare Procedures & Services
156 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 285 | 1,849 | $554,056 | $203,823 | 36.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 37 | 9,729 | $291,600 | $178,897 | 61.4% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 22 | 8,040 | $160,800 | $47,224 | 29.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 29 | 267 | $106,781 | $34,662 | 32.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 83 | 364 | $44,210 | $24,533 | 55.5% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 63 | 1,587 | $127,196 | $23,832 | 18.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 50 | 377 | $75,360 | $23,730 | 31.5% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 34 | 41,310 | $58,650 | $16,470 | 28.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 254 | 1,859 | $37,140 | $15,607 | 42.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 246 | 1,789 | $71,460 | $13,607 | 19.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 243 | 1,356 | $54,160 | $11,234 | 20.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 95 | 834 | $53,381 | $10,679 | 20.0% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 32 | 260 | $41,600 | $9,361 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 157 | $31,400 | $8,602 | 27.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 52 | $18,200 | $7,364 | 40.5% |
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 2023 | 11 | 28,142 | $28,140 | $7,173 | 25.5% |
| 80076 | Liver function blood test panel | Office | 2023 | 238 | 844 | $25,320 | $6,753 | 26.7% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 64 | 536 | $34,304 | $6,578 | 19.2% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 155 | 423 | $21,150 | $5,639 | 26.7% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 13 | 85 | $15,640 | $5,437 | 34.8% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 11 | 265 | $21,200 | $5,223 | 24.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $9,950 | $4,443 | 44.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 121 | 236 | $18,880 | $3,474 | 18.4% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 16 | 117 | $11,711 | $3,306 | 28.2% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 11 | 36 | $7,920 | $3,180 | 40.2% |
About Dr. Ann Wexler, MD
Dr. Ann Wexler, MD is a Specialist healthcare provider based in Berkeley, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669482576.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ann Wexler, MD has received a total of $65,736 in payments from pharmaceutical and medical device companies, with $7,147 received in 2024. These payments were reported across 1,445 transactions from 91 companies. The most common payment nature is "Food and Beverage" ($29,587).
As a Medicare-enrolled provider, Wexler has provided services to 10,885 Medicare beneficiaries, totaling 272,372 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 156 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Hematology & Oncology
- Location Berkeley, CA
- Active Since 08/09/2006
- Last Updated 08/07/2008
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1669482576
Products in Payments
- VERZENIO (Drug) $29,948
- REBLOZYL (Biological) $3,329
- KEYTRUDA (Biological) $1,440
- Lenvima (Drug) $920.78
- NINLARO (Drug) $788.77
- ZEJULA (Drug) $783.24
- IBRANCE (Drug) $677.42
- IMBRUVICA (Drug) $616.24
- OPDIVO (Biological) $576.05
- TAGRISSO (Drug) $474.03
- LIBTAYO (Biological) $469.71
- Revlimid (Drug) $438.62
- KISQALI (Drug) $432.05
- FOUNDATIONONE (Device) $386.83
- TUKYSA (Drug) $352.12
- Enhertu (Drug) $348.04
- ERLEADA (Drug) $335.43
- PADCEV (Biological) $330.32
- Neulasta (Biological) $309.26
- DARZALEX (Biological) $293.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Berkeley
Dr. Brad Lewis, M.d, M.D
Specialist — Payments: $204,406
Specialist $204,406
Terri Dunn, M.d, M.D
Specialist — Payments: $68,957
Specialist $68,957
Dr. Brad Zwahlen, M.d, M.D
Specialist — Payments: $11,968
Specialist $11,968
Dr. Faraz Berjis, M.d, M.D
Specialist — Payments: $5,445
Specialist $5,445
Dr. Michael Silpa, M.d, M.D
Specialist — Payments: $3,973
Specialist $3,973
Dr. David Irwin, M.d, M.D
Specialist — Payments: $1,810
Specialist $1,810